Background: There are no studies that have investigated the presence of yeasts in the subgingival oral biofilm (OB) of type-2 diabetic and non-diabetic patients with peri-implantitis. The aim was to assess the presence of yeasts in the subgingival OB of patients with type 2 diabetes and peri-implantitis and patients with peri-implantitis without diabetes.
Methods: Patients with type 2 diabetes with peri-implantitis (group A), non-diabetic individuals with peri-implantitis and without diabetes (group B), and individuals with and without peri-implantitis (group C) were included. Lifestyle-related and demographic data were collected using a questionnaire and hemoglobin A1c levels were measured. Peri-implant plaque index (PI), bleeding on probing (BOP), and probing depth (PD) were evaluated and crestal bone loss (CBL) were measured. Subgingival OB samples were collected and oral yeasts species were identified using ChromAgar medium. Level of significance was set at P <0.05.
Results: The mean age of individuals in groups A (n = 43), B (n = 41), and C (n = 42) were 55.6 ± 6.4, 54.6 ± 4.5, and 57.1 ± 3.3 years, respectively. The mean HbA1c levels were higher in group A (P <0.01) than groups B and C. Peri-implant PI (P <0.01), BOP (P <0.01), PD (P <0.01), and CBL (P <0.01) were significantly higher in group A compared with patients in groups B and C. Peri-implant PI (P <0.05), BOP (P <0.05), PD (P <0.05), and CBL (P <0.05) were significantly higher among patients in group B compared with group C. Subgingival yeasts were more often isolated from the OB of patients in groups A (74.4%) and B (46.3%) than group C (7.1%). The most common yeast species identified in all groups was Candida albicans. The CFU/mL for subgingival yeasts were higher in group A than groups B (P <0.01) and C (P <0.01). The CFU/mL for subgingival yeasts were higher in group B than group C (P <0.01).
Conclusion: Candida species (predominantly C. albicans) were more often present in the subgingival OB of patients with and without type 2 diabetes with peri-implantitis than systemically healthy individuals without peri-implant diseases.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/JPER.19-0091 | DOI Listing |
JMIR Diabetes
January 2025
Center for Evaluation and Survey Research, HealthPartners Institute, Bloomington, MN, United States.
Background: Food choices play a significant role in achieving glycemic goals and optimizing overall health for people with type 2 diabetes (T2D). Continuous glucose monitoring (CGM) can provide a comprehensive look at the impact of foods and other behaviors on glucose in real time and over the course of time. The impact of using a nutrition-focused approach (NFA) when initiating CGM in people with T2D is unknown.
View Article and Find Full Text PDFMedicine (Baltimore)
January 2025
Department of Endocrinology and Metabolism, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Background: This study evaluates the efficacy and safety of sitagliptin versus gliclazide, combined with metformin, in treatment-naive patients with type 2 diabetes mellitus (T2DM) and glucotoxicity.
Methods: In this single-center, randomized, controlled noninferiority trial, 129 treatment-naive patients with T2DM with glucotoxicity (fasting plasma glucose [FPG] ≥ 200 mg/dL and glycated hemoglobin ≥ 9.0%) were randomized to receive sitagliptin plus metformin (n = 66) or gliclazide plus metformin (n = 63) for 12 weeks.
Medicine (Baltimore)
January 2025
The Department of Clinical Laboratory, Zhejiang Hospital, Hangzhou, China.
Rationale: Gitelman syndrome (GS) is a rare hereditary electrolyte disorder caused by mutations in the SLC12A3 gene. There is limited literature on the role of hydrochlorothiazide (HCT) testing and the SLC12A3 single heterozygous mutation in the diagnosis and management of patients with GS. In addition, cases of GS with concomitant kidney stones are rare.
View Article and Find Full Text PDFSci Adv
January 2025
Department of Physiology, University of Toronto, Toronto, Ontario, Canada.
Gestational diabetes mellitus (GDM), a transient form of diabetes that resolves postpartum, is a major risk factor for type 2 diabetes (T2D) in women. While the progression from GDM to T2D is not fully understood, it involves both genetic and environmental components. By integrating clinical, metabolomic, and genome-wide association study (GWAS) data, we identified associations between decreased sphingolipid biosynthesis and future T2D, in part through the allele of the gene in Hispanic women shortly after a GDM pregnancy.
View Article and Find Full Text PDFComput Inform Nurs
January 2025
Author Affiliations: Duke University School of Nursing (Drs Lee, Silva, Yang, Hatch, and Shaw and Mss Pennington, Matters, and Urlichich); and Duke University School of Medicine (Dr Crowley), Durham, NC.
Digital health literacy is emerging as an important element in chronic illness management, yet its relationship with clinical outcomes remains unclear. Utilizing data from the ongoing EXpanding Technology-Enabled, Nurse-Delivered Chronic Disease Care trial, this cross-sectional, correlational study explored the association between digital health literacy, health literacy, and patient outcomes, specifically blood pressure and hemoglobin A1c levels in 76 patients managing comorbid type 2 diabetes and hypertension. Results indicate patients had moderate digital health literacy, which was not significantly correlated with health literacy (r = 0.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!